載入...
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
BACKGROUND: Preclinical studies suggest that chemotherapy may enhance the immune response against pancreatic cancer. METHODS: The levels of granulocyte macrophage-colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6) and the associated inflammatory marker C-reactive protein (CRP) were assessed...
Na minha lista:
| 發表在: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782200/ https://ncbi.nlm.nih.gov/pubmed/26931369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.468 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|